SCHEMBL8773390

SCHEMBL8773390

Cc1ccc2oc(O)cc(=O)c2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 3/20 0.62
CSNK2B P67870 3/20 0.62
CSNK2A1 P68400 3/20 0.62
MAPT P10636 3/20 0.58
HTT P42858 1/20 0.58
KDM4E B2RXH2 4/20 0.57
ALDH1A1 P00352 3/20 0.57
TP53 P04637 2/20 0.57
CYP3A4 P08684 2/20 0.57
HPGD P15428 2/20 0.57
HSD17B10 Q99714 2/20 0.57
MAPK1 P28482 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
NQO1 P15559 1/20 0.53
POLB P06746 2/20 0.51
KCNA5 P22460 1/20 0.51
KCNH2 Q12809 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL266614 0.81 MAPT (0.63) CSNK2A2CSNK2BCSNK2A1MAPTHTT
SCHEMBL13347724 0.78 MAPT (0.63) CSNK2A2CSNK2BCSNK2A1MAPTHTT
SCHEMBL28304255 0.78 MAPT (0.58) CSNK2A2CSNK2BCSNK2A1MAPTHTT
SCHEMBL8265824 0.77 POLB (0.62) CSNK2A2CSNK2BCSNK2A1MAPTHTT
SCHEMBL379054 0.77 ALDH1A1 (0.67) CSNK2A2CSNK2BCSNK2A1MAPTHTT
SCHEMBL30643052 0.77 POLB (0.62) CSNK2A2CSNK2BCSNK2A1MAPTHTT
SCHEMBL5433487 0.77 CSNK2A2 (1.00) CSNK2A2CSNK2BCSNK2A1MAPTKDM4E
SCHEMBL5211481 0.76 POLB (0.60) CSNK2A2CSNK2BCSNK2A1MAPTHTT
SCHEMBL23334588 0.75 MAPT (0.73) CSNK2A2CSNK2BCSNK2A1MAPTHTT
SCHEMBL10024074 0.75 CSNK2A2 (0.82) CSNK2A2CSNK2BCSNK2A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778970-B2 Benzyl piperidine compound DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2014-07-15 US disclosed
US-8778970-B2 Benzyl piperidine compound DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2014-07-15 US disclosed
EP-2463286-A1 BENZYL PIPERIDINE COMPOUND Dainippon Sumitomo Pharma Co., Ltd. (JP) 2012-06-13 EP disclosed
US-20120130077-A1 BENZYL PIPERIDINE COMPOUND DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-05-24 US disclosed
US-20120130077-A1 BENZYL PIPERIDINE COMPOUND DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-05-24 US disclosed
WO-2011016468-A1 BENZYL PIPERIDINE COMPOUND 大日本住友製薬株式会社 (JP) 2011-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120130077-A1 BENZYL PIPERIDINE COMPOUND HTR1D, HTR1A, HTR1B CSNK2A2 2667/4885CSNK2B 2818/4885CSNK2A1 2407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.